title: Cost evaluation of basiliximab treatment for renal transplant patients in Japan.
authors.affiliation: Department of Public Health, Toho University School of Medicine, Tokyo, Japan. tommie@med.toho-u.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Hasegawa
authors.forename: H
authors.initials: H
authors.lastname: Imai
authors.forename: S
authors.initials: S
authors.lastname: Miki
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use; D000077552:Basiliximab; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use; D007564:Japan; D016030:Kidney Transplantation / Q000191:economics / Q000276:immunology*; D011993:Recombinant Fusion Proteins
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab